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and Protein Kinase C on Conformational Change and ATPase Activities of 
Human Platelet Myosin 
By Masaaki Higashihara, Kyoya Takahata, and Kiyoshi Kurokawa 
Human platelet myosin  forms 10s and 6s conformations, and 
its Ca*+- and  Mg*+-ATPase activities are  parallel with the 
transition between 10s and 6s conformation, as judged by 
the gel filtration, intrinsic fluorescence, and viscosity meth- 
ods. The 20,000-dalton myosin light chain (LC20) is phospho- 
rylated by both myosin light chain kinase (MLC kinase) and 
Ca”,  phospholipid-dependent protein kinase (protein kinase 
C [PKC]). The phosphorylation (1 mol of  phosphate/mol of 
LC20) by MLC kinase shifts the equilibrium toward the 6s 
conformation, but  that by PKC does not. The prephosphoryla- 
LATELETS  PLAY  an important  role  in  hemostasis  P  and thrombus formation.’ In platelet cytoplasm, con- 
tractile proteins such as actin and myosin are the dominant 
proteins that are thought to have important roles in cellular 
activation.’” Activation of  platelet phosphoinisitide-specific 
phospholipase C results in the generation of  diacylglycerol 
and  inositol  triphosphate  (IP,).4 Diacylglycerol activates 
eaZ+,  phospholipid-dependent protein kinase (protein ki- 
nase C [PKC]), and then 47-Kd protein is mainly phospho- 
rylated? IP, releases Ca’+  from the Ca”  pool, resulting in 
an increase in intracellular Ca’+  ([Ca’+]i).6  The increase in 
[Ca’+]i activates Ca”/calmodulin-dependent myosin light 
chain kinase (MLC kinase), and then a 20-Kd MLC (LC20) 
is phosphorylated,’  resulting in the activation of the actin- 
activated M&+-ATPase  activities of platelet myosin*  as well 
as smooth muscle my~sin.~  Initially, only MLC kinase was 
thought to phosphorylate  LC20, but  recently it has been 
recognized that PKC phosphorylates  the LC20 of  gizzard 
smooth muscle myosin at a different site’o3’’  and causes a 
reduction in actin-activated M$+-ATPase activity of heavy 
meromyosin (HMM) compared with the activity obtained 
after phosphorylation  by  only  MLC  Pretreat- 
ment of  intact platelets with PKC inhibitor, H-7 promoted 
the serotonin release by  phorbol  12-myristate 13-acetate 
(TPA), suggesting that phosphorylation of  myosin by PKC 
inhibits the release reaction.” Naka et all4  recently reported 
that doubly phosphorylated MLC was detected in thrombin- 
stimulated human platelets, and that one of  these sites was 
phosphorylated  by  PKC  and  the other by  MLC  kinase. 
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tion of myosin by PKC prevents the effect of phosphorylation 
by MLC kinase on actin-activated Mg’+-ATPase activity, but 
not the effect on conformational change. Inhibition of actin- 
activated ATPase  activity by  PKC  is due  to  a  decreased 
affinity of  myosin for  actin,  and  no  change  in  Vmax  is 
observed. These results suggest that sequential phosphoryla- 
tion of myosin by both kinases plays an important role in the 
ATPase activities  of human platelet myosin. 
o 1991 by The American Society of Hematology. 
Thus, the effects of  phosphorylation by both kinases should 
be considered in evaluating the role of myosin phosphoryla- 
tion in the platelet activation. 
as well as smooth muscle 
in the monomeric state are reported to exist in 
two conformations, ie, the folded (10s) and extended (6s) 
forms. In smooth muscle myosin, these conformations are 
characterized by  distinct enzymatic properties,D ie, 6s  is 
active and 10s is inactive. Among the nonmuscle myosins 
characterized so  far, only myosins from  bovine erythro- 
cytes” were shown to have correlation of enzymatic proper- 
ties and conformations. 
In this report, we show that human platelet myosin also 
shows the correlation of enzymatic properties and conforma- 
tions. The effects of phosphorylation by MLC kinase andlor 
PKC on the myosin function are also investigated. 
Some nonmuscle 
MATERIALS AND METHODS 
Materials.  Ovomucoid  trypsin  inhibitor, [ethylenbis(oxyethyl- 
enenitrilo)] tetraacetic acid (EGTA),  disodium ethylendiaminotet- 
racetate (EDTA), ATP, phenylmethylsulfonyl  fluoride (PMSF), 
dithiothreitol (DTT), and TPA were obtained from Sigma Chemi- 
cal Co (St Louis, MO). Sodium dodecyl sulfate (SDS), acrylamide, 
and urea were purchased from Wako Pure Chemical Industries, 
Ltd  (Osaka, Japan).  [y-’*P]ATP was  obtained from Amersham 
Japan Ltd (Tokyo, Japan). Other  materials are  of the highest grade 
available. 
Platelet  myosin  was  prepared  as  follows.  Platelet 
concentrates (15 U) were washed with phosphate-buffered saline 
(PBS; pH 7.3)  once, and resuspended in HEPES-Tyrode’s buffer 
with  4  mmol/L EGTA,  4  mmol/L EDTA, 0.1 mg/mL  trypsin 
inhibitor, 4 mmol/L DTT, 1 mmol/L PMSF, and 0.04% sodium 
azide. Platelets were resuspended with the same volume of buffer 
A  (0.5 mol/L KCl, 0.15  mol/L potassium phosphate, pH 6.8,  2 
mmol/L EGTA, 2 mmol/L EDTA, 0.2 mg/mL trypsin inhibitor, 
and 1 mmol/L PMSF) and sonicated for 5 minutes on  ice. Two 
volumes of  buffer A were further added, and the suspension was 
put in ice for 60 minutes. After the suspension was centrifuged at 
48,OOOg  for  120 minutes  at  4”C,  the  supernatant was dialyzed 
against buffer B (10 mmol/L  imidazole, pH 7.0, 10 mmol/L MgCI,, 
2 mmol/L EGTA, 1  mmol/L DTT, and 5%  sucrose). The pellet by 
centrifugation at  10,OOOg  for 15 minutes was washed once with 
buffer B, and centrifuged again as above. The pellet was dissolved 
in  buffer  C  (0.5 mol/L NaC1,  30  mmol/L Tris-HCI,  pH 7.5,  1 
mmol/L EGTA, 1 mmol/L PMSF,  and  1 mmol/L DlT) and 
subjected on  Sepharose CL-4B column (3 cm X 90 cm)  equili- 
brated with buffer C. The crude myosin fractions  judged by SDS  gel 
Proteins. 
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electrophoresis were collected and dialyzed against buffer B. The 
pellet by  centrifugation at 10,OOOg for 15 minutes was dissolved in 
0.15 mol/L MgCl,,  1  mmol/L EGTA, 5 mmol/L ATP, 5 mmol/L 
DTT, 50  mmol/L Tris-HC1, pH 7.5.  The protein  solution was 
centrifuged at  10,OOOg  for  3  hours,  and  the  supernatant  was 
subjected to Sepharose CL-4B column equillibrated with buffer C 
with  1 mmol/L  MgCl,,  0.5  mmol/L  ATP.  The  pure  myosin 
fractions, as judged by  SDS gel  electrophoresis, were combined 
and dialyzed against 0.5 mol/L KCl, 30 mmol/L Tris-HC1, pH 7.5,5 
mmol/L DTT, and stocked in ice. The purity was greater than 95% 
as  judged by  the  densitometry of  a Coomassie Brilliant  Blue- 
stained gel. 
MLC kinasez1  and calmodulin,u gifts of  Dr Ikebe (Case Western 
Reserve University), were prepared from turkey gizzard and bull 
testes,  respectively. PKC was  prepared  from  bovine  brain  as 
described according to Kikkawa et  Actin was prepared from 
rabbit skeletal muscle according to the method of  Driska  and 
Hartshome.”  Chicken gizzard myosin was prepared according to 
the method of Ikebe and Hartshorne.z 
ATPase assay was per- 
formed as described previ0us1y.l~  The extent of  phosphorylation 
was measured by  the method of  Mrwa and Hartshorne.%  Platelet 
myosin  (0.8 mg/mL) was  phosphorylated at 25°C  either with  2 
pg/mL  MLC  kinase  and  1 kg/mL  calmodulin  in  a  solution 
containing 0.1  mmol/L  CaCl,,  1 mmol/L  MgCl,,  0.5  mmol/L 
[y-”P]ATP, 30 mmol/L Tris-HCI, pH 7.5, and 0.1 mol/L KCl, or 
with  2  pg/mL  PKC,  100  pg/mL  phosphatidylserine, and  100 
ng/mL TPA in a solution containing 0.1 mmol/L CaCl,,  1  mmol/L 
MgCl,,  0.5 mmol/L [y-3’P]ATP, 30 mmol/L Tris-HC1, pH 7.5, and 
60  mmol/L  KCl.  Reactions were  stopped  by  addition of  5% 
trichloroacetic acid. Myosin phosphorylated by  MLC kinase plus 
PKC was obtained as follows. Platelet myosin (1.0 mg/mL) was 
phosphorylated by  MLC  kinase  for  15  minutes  at  25°C.  The 
reaction was stopped by  addition of  EGTA (1 mmol/L in final), 
and the solution was dialyzed against 10 mmol/L MgCI,, 1  mmol/L 
EGTA,  30  mmol/L  Tris-HCl, pH  7.5,  2  mmol/L  DTT.  The 
precipitate, after centrifugation at  10,000g for  15 minutes, was 
dissolved  in  50 mmol/L KCl,  1 mmol/L DTT, and 30  mmol/L 
Tris-HC1, pH 7.5.  The level of  phosphorylation was checked by 
urea gel electroph~resis,~~  and the level was approximately 1  mol of 
phosphate/mol of LC20. The myosin was then incubated with PKC 
solution for 60  minutes, and  then  dialyzed  against 10 mmol/L 
MgCI,,  1 mmol/L DTT, and 30 mmol/L Tris-HCl, pH 7.5.  The 
precipitate was  collected by  centrifugation (10,OOOg  for 10 min- 
utes), and dissolved in 0.4  mol/L KCI,  2 mmol/L DTT, and 30 
mmol/L Tris-HCl,  pH 7.5. 
ATPase activities and phosphorylation. 
Other conditions are given in the figure legends. 
Viscosity.  Viscosity was measured at 23°C in Cannon-Ubbelo- 
hode viscometers (Cannon Instrument CO,  State College, PA) with 
a water flow of  approximately 54 seconds. The myosin concentra- 
tion  was  0.5  mg/mL. The viscosity  data  are  expressed  as  q,, 
(viscosity of  protein solution/viscosity  of solvent). 
Sedimentation  velocity.  Sedimentation velocity measurements 
were performed in a Beckman Model E analytical ultracentrifuge 
(Beckman Instruments, Inc, Palo Alto, CA) operated  at 56,000 
rpm, as described by Umekawa et a1.2’ Platelet myosin was dialyzed 
against 1  mmol/L ATP, 1  mmol/L MgCl,, 30 mmol/L Tris-HC1, pH 
7.4, and 0.1 mol/L KCl or 0.4  mol/L KCl. Another 0.5 mmol/L 
ATP was added to the sample solution  just before analysis. Myosin 
concentration was adjusted to 0.8 mg/mL. The value of  sedimenta- 
tion coefficient (Sm, w x lo-”  seconds) was  the  mean of  three 
experiments  in each sample. 
The TSK  4000SW  column  was  attached  to  a 
TOSO high performance liquid chromatography (HPLC) system 
(Toyo Soda Industries Ltd, Tokyo, Japan)  at a flow  rate of  0.7 
Gel filtrurion. 
mL/min. Platelet myosins were dialyzed against 1  mmol/L MgCI,, 
0.1  mmol/L ATP,  30  mmol/L Tris-HCl, pH  7.0,  and various 
concentrations of  KCl (0.1 to 0.5  mol/L KC1).  The bed  volume 
determined with  DTT was  20.8  minutes, and the void  volume 
determined with blue-dextran  was 8.80 minutes. 
Fluorescence  was measured 
at 25°C  with  a Shimazu UV-2100 spectrofluorometer equipped 
with  a cell  holder temperature-controlled by  circulating water. 
Excitation and emission wavelengths were 295  nm  and 335  nm, 
respectively. 
Others.  Protein concentrations  were determined by the method 
of  Bradf0rd.2~  SDS gel electrophoresis was performed in  12.5% 
polyacrylamide  slab gels (SDS-PAGE).  Gels were stained in 0.06% 
Coomassie  Brilliant  Blue  R-250  (Sigma).  Silver  staining was 
performed as described previo~sly.’~ 
Intrinsic fluorescence measurement. 
RESULTS 
Phosphorylation of platelet myosin by MLC kinase or PKC. 
Purified platelet myosin consists of  an approximate 200-Kd 
heavy chain and two light chains of  20 Kd  and 17 Kd in 
SDS-PAGE, as reported by others?.’ To  prevent phosphory- 
lation  during  preparations,  we  first  applied  low  ionic 
strength precipitation followed by Sepharose CL-4B chro- 
matography without Me-ATP.  Finally, rechromatography 
with Sepharose CL-4B with Mg2+-ATP  was used to separate 
the contaminated actin. The purity was greater than 95% as 
judged by  the densitometry of  a Coomassie Brilliant Blue- 
stained gel (data not shown). Figure 1  shows the data on the 
time course of  phosphorylation of  purified myosin by both 
kinases. In our conditions, 0.9 to 1.0 mol of  phosphate per 
mole of  LC20 was maximally incorporated by  MLC kinase 
and 1.8 to 2.1 mol of phosphate per mole of  LC20 by PKC in 
five separate experiments. In addition, prephosphorylated 
myosin by  MLC kinase (1 mol of  phosphate/mol of  LC20) 
was further phosphorylated with two  more phosphate/mol 
of  LC20 by PKC (Fig 1). Reversing the order of  incubation 
with kinase (ie, phosphorylation with PKC first and then 
with MLC kinase) also resulted in 3 mol of  phosphate/mol 
of  LC20 (data not  shown). Although  the autoradiogram 
shows that only LC20 was phosphorylated by both kinases 
(inset in Fig l),  the heavy chain of myosin treated with PKC 
was found to be slightly phosphorylated with a prolonged 
incubation,  ie,  2.5  hours  (data  not  shown). Aliquots  of 
myosin from each phosphorylation  series were applied to 
urea gel electrophoresis (inset in Fig 1). Purified myosin 
was mostly dephosphorylated because  the band of  LC20 
(LC20. PO)  was single and the mobility was the same as 
that of  myosin treated with phosphatase (data not shown), 
and  a  single phosphorylated  band  (LC20. P1) was seen 
with MLC kinase with 20 minutes of  incubation. In the case 
of  PKC, a more rapidly migrating doubly phosphorylated 
light chain (LC20 .  P2) was also observed with 20 minutes 
of  incubation,  and,  finally,  only  LC20  .  P2  band  was 
observed with 80 minutes of  incubation (data not shown). 
Conformational  change  of  dephosphorylated myosin  of 
human platelets.  Conformational change was monitored 
by  analytical ultracentrifugation. The sedimentation coeffi- 
cient values at 0.4 mol/L KCl were 9.5, 9.6,  and 10.0 for 
three myosin samples prepared separately, and 6.2,6.0, and 
6.1, respectively, at 0.1 mol/L KC1. 
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Time  (min) 
Flg 1.  Time course of phosphorylation  of platelet  myosin by MLC  kinase andlor PKC. Platelet  myosin (0.8 mglml)  was phosphorylated  at 25% 
with either MLC kinase solution (0)  or PKC solution (01,  as doseribad in Materials  and Methods. Reactions  were stopped either by the addition of 
5% trichloroacetic  acid (for phosphorylatlon  assay) or by the addition  of urea to 8 mol/ L (for urea gel electrophoresis). Myosin prephosphorylated 
by MLC kinase for a 20-minute reaction period was further phosphorylated by adding PKC solution (final reaction solution was the same as 
mentioned above). The inset shows the autoradiogram of 12.5% SDS-PAGE (A) and silver staining of urea-gel electrophoresis (B).  Myosin 
phosphorylated  by MLC kinase for 20 minutes (lanes 1 and 5) or PKC for 20 minutes (lanes 2 and 4); dephosphorylated  myosin (lanes 3 and 6). Four 
micrograms of myosin was applied to each gel lane. LC20,20-Kd MLC; LC20. PO, dephosphorylated  LC20; LC20. P1, single-phosphorylated  LC20; 
LC20. P2, double-phosphorylated  LC20; LC17,17-Kd MLC. 
Correlation of  enzymatic activity and conformation.  Fig- 
ure 2 shows the data of  KCI-dependence of  Cat+-ATPase 
activities of  platelet myosin.  Between 0.1  and 0.2  mol/L 
KCI, the ATPase activity was very low. The activity showed 
a  sharp  increase between  0.2  and  0.3  mol/L  KCI  and 
reached a plateau over 0.3 mol/L KCI. 
To investigate the correlation of  enzymatic activity and 
myosin conformation, gel filtration technique was applied. 
According to previous reports,”*” 6s myosin eluted faster 
than  10s myosin.  Figure 3 shows the elution time as the 
function of  KCI  concentration. The elution time changed 
rapidly between 0.2  and 0.3  mol/L KCI.  Taken together 
with the result of  KCI-dependence of  Ca’+-ATPase activity 
(Fig 2), this finding led us to conclude that the elution time, 
which represents the conformational change, is paralleled 
by  the Ca’+-ATPase  activity. 
The Gect of  phosphorylation  on KCI-dependence of Mf- 
ATPase activity.  The correlation of  KCI-dependence of 
Ca’+-  and M$’-ATPase  activities and conformation was 
previously shown for smooth muscle myosin.”  Thus, KCI- 
dependence of  M&+-ATPase  activity was also investigated 
for platelet myosin. Furthermore, the effect of phosphoryla- 
tion by  MLC kinase or PKC on the M&+-ATPase  activities 
was monitored (Fig 4).  For the dephosphorylated platelet 
myosin, the change of Me-ATPase activity as the function 
of  KCI concentration showed almost the same dependency 
as that of  Ca’+-ATPase activity (Fig 2). The phosphoryla- 
tion by  MLC kinase (1 mol  of  phosphate/mol of  LC20) 
shifts the equilibrium toward the low concentration of KCI, 
ie, at the concentration of  0.2  mol/L KCI,  M$+-ATPase 
activity of phosphorylated myosin was as high as that at 0.3 
mol/L KCI. At 0.1 mol/L KCI, the activity was as high as 
that of  dephosphorylated myosin  at 0.25  mol/L KCI.  In 
contrast, neither  M&+-ATPase activity  of  dephosphory- 
lated myosin nor that of prephosphorylated myosin by  MLC 
kinase was affected by  PKC phosphorylation. 
The effect of  phosphorylation on the  KCI-dependence of 
viscosiy.  The viscosity is another probe for the measure- 
ment of conformational change of myosin.” The decrease in 
the viscosity of  gizzard myosin was shown to be due to the 
change  in  myosin  conformation  from  an  extended (6s 
myosin) to a folded (10s myosin) form.”  Like the gizzard 
myosin, the viscosity of  dephosphorylated platelet myosin 
at 0.1 mol/L KCI was low (Fig 5). On the other hand, at 0.4 
mol/L KCI, viscosity was high. The change of  viscosity of 
dephosphorylated platelet myosin  as the function of  KCI 
concentration showed a similar pattern as KCI-dependence 
of Ca’+- and M$+-ATPase activities. These results provide 
For personal use only. on November 3, 2014.  by guest    www.bloodjournal.org From PHOSPHORYLATION OF PLATELET MYOSIN  3227 
Fig 2.  KCI-dependence  of Ca'+-ATPase activity of platelet myosin. 
ATPase activity was assayed with myosin (0.24 mg/mL), 10 mmol/L 
CaCI,,  30 mmol/L  Tris-HCI, pH  7.5,0.5  mmol/L  [yUP]ATP, and various 
concentrations of KCI at 25°C. 
further support for the correlation of  enzymatic properties 
and conformation of  platelet myosin. The phosphorylation 
by  MLC kinase  shifted  the equilibrium  toward  the low 
concentration  of  KC1,  ie,  at 0.2 mol/L KCl, viscosity of 
myosin phosphorylated by MLC kinase was as high as that 
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Fig 3.  The elution time of platelet myosin as  a function of  KCI 
concentration. Myosin samples (0,  A)  were prepared separately. The 
TSK 4OOOSW  column was used (see Materials and Methods). Each 
value is  the mean of two experiments. 
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Fig 4.  The effect of phosphoylation on KCI-dependence of Mg"- 
ATPase  activity.  ATPase  activity  was assayed with myosin (0.24 
mg/mL), 1  mmol/L MgCI,,  30 mmol/L Tris-HCI, pH 7.5,  0.5  mmol/L 
[y-UP]ATP,  and  various  concentrations  of  KCI.  Dephosphorylated 
myosin (0);  phosphorylated  myosin by MLC kinase (A); PKC (0); 
MLC kinase plus PKC (A).  The conditions of phosphorylation  were the 
same as in Fig 1.  The extent of phosphorylation  was 1.0 mol, 1.8 mol, 
and 2.7 mol of phosphate/mol of LC20 for MLC kinase, PKC and MLC 
kinase plus PKC, respectively. 
of  dephosphorylated myosin at 0.3  to 0.4 mol/L KC1 (6s 
myosin). The viscosity of  neither dephosphorylated myosin 
nor myosin prephosphorylated by MLC kinase was affected 
by PKC phosphorylation. 
The effect  of phosph61ylation on intrinsic fluorescente of 
myosin.  In the inset of  Fig 6A are shown the fluorescence 
emission spectra of  human platelet myosin before and after 
addition of 0.1 mmol/L ATP in the presence of MgCI,.  The 
fluorescence intensity at 335  nm was enhanced by  about 
15% on addition of  ATP. At 0.2 mol/L KCl, the fluores- 
cence level of  myosin (10s myosin) was higher than that at 
0.3 mol/L KC1 (6s myosin) with addition of  ATP (Fig 6A 
and B). At 0.2 mol/L KC1 in the presence of  MLC kinase 
and calmodulin, the addition of  0.1 mmol/L CaC1, resulted 
in a decrease of  fluorescence (Fig 6A), whereas the addi- 
tion  of  EGTA did not  change  the fluorescence  intensity 
(data not  shown). In contrast,  at 0.3  mol/L KCl  in  the 
presence of  MLC kinase and calmodulin, the fluorescence 
level did not change after the addition of  CaC1,. A similar 
experiment performed in the presence of  PKC, phosphati- 
dylserine, and TPA, with the addition of  CaCl,,  showed a 
constant level of fluorescence (data not shown). 
The  effect  of  phosphorylation  on  actin-activated M,+- 
ATPase  activity and  myosin  conformation.  As  shown  in 
Table 1, phosphorylation of  platelet myosin by PKC alone 
had  no  effect  on  actin-activated  M$'-ATPase  activity, 
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Fig 5.  The effect of phosphorylation  on KCI-dependence of viscos- 
ity. Dephosphorylated myosin (0);  phosphorylated myosin by MLC 
kinase (A); PKC (a);  MLC kinase plus PKC (A).  Conditions were the 
same as those in Fig 4. 
wherease  phosphorylation  by  MLC kinase  resulted  in  a 
15-fold increase  in  actin-activated  MgZ'-ATPase activity 
over that of  dephosphorylated myosin. The myosin  maxi- 
mally phosphorylated by both kinases (3 mol of  phosphate/ 
mol of LC20) was accompanied by a decrease of about 40% 
in the actin-activated MgZ'-ATPase activity, compared with 
that of  myosin phosphorylated by  MLC kinase alone. The 
sedimentation coefficients in solutions containing 0.2 mol/L 
KCI  were  measured  for  four  species  (dephosphorylated 
myosin, myosin  phosphorylated  by  MLC  kinase,  myosin 
phosphorylated  by  PKC,  and  myosin  phosphorylated  by 
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Table 1.  Effects of Phosphorylation on Actin-Activated Mg"-ATPase 
Activities and Myosin Conformations 
MgZ+-ATPase  Activity 
Sedimentation 
Coefficient  (nmollmin .  mg myosin)t 
(S2,,,  w X  sed*  +Actin  -Actin 
Dephosphorylated  myosin  9.8  2.5  ? 0.3  2.3  2 0.2 
Phosphorylated  myosin 
MLC kinase alone  6.1  38.6  ? 2.5  3.4 * 0.4 
PKC alone  9.9  2.8 ? 0.1  2.3 k 0.2 
MLC kinase and PKC  6.2  22.7  ? 3.0  3.2  2 0.5 
~  __ 
Myosin was  prephosphorylated by  MLC  kinase and/or  PKC  (see 
Materials  and Methods).  ATPase activity was assayed with 0.25 mg/mL 
myosin, 4 mmol/L MgCI,,  60 mmol/L KCI, 30 mmol/L Tris-HCI, pH 7.5, 
0.5 mmol/L [y-32P]ATP  with or without actin (1 mg/mL) at 25°C. 
'Mean  of three samples. Standard deviation (SD) was within 3%. 
tMean ? SD of four to five determinants. 
both  kinases).  Sedimentiation  coefficients were  9.8  for 
dephosphorlated myosin, 6.1 for MLC kinase, 9.9 for PKC, 
and 6.2 for both kinases (Table 1). 
Figure  7 shows the actin dependence  of  Mg2'-ATPase 
activity of  platelet myosin. For myosin  phosphorylated  by 
MLC kinase alone (to approximately 1 mol of  phosphate/ 
mol of  LC20), the Ka  (apparent dissociation constant for 
actin) and Vmax are 10.2 p,mol/L and 56 nmol/(min .  mg), 
respectively. Additional phosphorylation of  platelet myosin 
by  PKC (an additional 2.1 mol of  phosphate/mol of  LC20) 
did not alter Vmax, but increased Ka to 45 p,mol/L. 
DISCUSSION 
The study described in this report showed that LC20 of 
purified human platelet myosin was phosphorylated by both 
MLC kinase  and  PKC.  The analysis of  two-dimensional 
peptide mapping previously showed that the phosphoryla- 
tion of  LC20 by both kinases actually occurred in thrombin- 
stimulated human platelet~.'~  Thus, the effects of  phospho- 
rylation of LC20 by both kinases on myosin function should 
be considered in evaluating the role of  myosin in platelet 
activation. In some vertebrate and invertebrate nonmuscle 
ii 
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Fig 6.  The effect of phosphorylation on the intrin- 
sic fluorescence of platelet myosin. ATP (0.1 mmol/L, 
open arrow; zero time) was added to  myosin  solution 
containing myosin (0.5  mg/mL),  MLC kinase (2 pg/ 
mL), calmodulin (2 pg/mL), 30 mmol/L Tris-HCI (pH 
7.5).  4 mmol/L MgCI,,  and either (A) 0.2  mol/L KCI or 
(B) 0.3 mol/ L KCI, and then CaCI,  (0.2 mmol/L, closed 
arrow in A and B) or EGTA (1  mmol/L) (not shown) 
was  added.  Inset  in (A)  shows the  fluorescence 
spectra of human platelet myosin. (a) Before and (b) 
after addition of ATP (0.1 mmol/L). 
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Fig 7.  Effect of the phosphorylation by PKC on the actin-activated 
ATPase activity of  platelet myosin. Platelet myosin was phosphory- 
lated by MLC kinase alone or  MCL kinase plus PKC with eonditions as 
in Fig 1 at 25°C. ATPase activity  was assayed with 0.2 mg/mL myosin, 
4 mmol/L MgCI,,  60 mmol/L KCI, 30 mmol/L Tris-HCI, pH 7.5, 0.5 
mmol/L  [r”P]ATP,  and  various  concentrations of  actin  at  25°C. 
Myosin  phosphorylated by MLC kinase alone (0);  myosin phosphory- 
lated by MLC kinase plus PKC (0). 
myosin, phosphorylation  of  myosin heavy chain was also 
detected?’Although  phosphoIylation of myosin heavy chain 
catalyzed  by  PKC was  recently  reported in  both  intact 
human platelets and purified platelet myosin:’  the extent of 
heavy-chain phosphorylation of  purified myosin was small 
under our experimental conditions, so the effect of  heavy- 
chain  phosphorylation  on the conformational change  or 
actin-myosin interaction was not studied in this study. We 
tried to use the same conditions for PKC phosphorylation 
of purified platelet myosin as those reported by Kawamoto 
et a1;l  and the extent of  heavy chain phosphorylation was 
also small. One possible explanation  is  that the putative 
myosin  binding  proteins  in  intact  platelet  cytoplasm or 
purified protein(s), ie, PKC solution, may alter the environ- 
ment of the heavy-chain phosphorylation sites. 
One of the striking findings is that sequential phosphory- 
lation was achieved (3 mol of phosphate/mol of  LC20) by 
MLC  kinase  plus  PKC.  One  mole  of  phosphate  was 
maximally phosphorylated by  MLC kinase, and 2 mol of 
phosphate  by  PKC  (Fig  1).  These results  suggest  that 
phosphoamino acids of  the two kinases are different. In a 
preceding study, Ikebe and Reard~n’~,~~  reported that in 
bovine  platelet  myosin,  the  phosphorylation  site  was 
serine-19 by MLC kinase and threonine-9 and serine-1 or 
serine-2 by  PKC, although additional phosphate was incor- 
porated under certain experimental conditions. These sites 
are  identical  with  the  phosphorylation  sites  of  smooth 
muscle  HMM.’O3’’ Independently,  Kawamoto  et  a1:’  by 
comparing two-dimensional tryptic mapping with  that  in 
gizzard  smooth  muscle  LC20,  reported  that  serine-1, 
serine-2,  and  threonine-9  of  LC20  of  purified  human 
platelet myosin was phosphorylated by PKC, whereas there 
was very  little  phosphorylation  of  threonine-9  in  intact 
platelets after treatment with TPA. Although  amino acid 
sequences of  human  platelet  myosin  have  not  been  re- 
ported yet, phosphoamino acids of  human platelet myosin 
by  both kinases are expected to be the same as those of 
bovine platelet m~osin~”~~  and gizzard myo~in.’~~’’~~~ 
The  analytical  ultracentrifugation  study  showed  that 
human platelet myosin forms 10s conformations at low (ie, 
0.1 mol/L KC1) ionic strength and 6s conformations at high 
(ie,  0.4  mol/L KCI)  ionic  strength.  These results  were 
consistent with those described previously by Takashima et 
Conformational  change  was  also  reported  with  a 
vertebrate  nonmuscle  myosin  from  brush  border,15 thy- 
mus,I6 or bovine  erythrocytes.”  We  further showed that 
these conformational  change are paralleled  by  enzymatic 
activities, ie, Caz+-  and Mg2+-ATPase activities using gel 
filtration  and viscosity methods  (Figs 2 through  5). The 
enzymatic activity that is subject to regulation in vivo is the 
actin-activated ATPase activity of myosin. The major contri- 
bution derived from the experiments in the absence of actin 
discussed above is the realization that two conformations of 
myosin possess different enzymatic properties. This prop- 
erty  was  previously  shown with  gizzard  smooth  muscle 
myosinm  and bovine erythrocyte myosin,I7  and recently with 
bovine platelet myosin.33  Thus, the ‘shape-activity’  hypothe- 
sis  for  smooth  muscle  myosin  developed  by  Ikebe  and 
Hartshorne’ may  be extended to some of  the nonmuscle 
myosins. 
There are apparent differences in the effects of phospho- 
rylation on biochemical properties  of  platelet  myosin  be- 
tween  the  two  kinases.  One  difference  is  the  effect  of 
phosphorylation on the 10s to 6s  transition.  MLC kinase 
phosphorylation  shifted the equilibrium toward 6S, ie, at 
0.1  mol/L  KCl  viscosity  and  MgZ+-ATPase activity  of 
phosphorylated  myosin are about the same as that at 0.22 
mol/L  KCl  and  0.25  mol/L  KCI  of  dephosphorylated 
myosin, respectively. In contrast, PKC phosphorylation had 
no  effect.  Moreover,  MLC  kinase  phosphorylation  in- 
creased the actin-activated ATPase activity about 15-fold, 
whereas PKC phosphorylation had no effect (Table 1). To 
confirm the effects of  phosphorylation on conformational 
change  at 0.2 mol/L KCI,  intrinsic  tryptophane  fluores- 
cence,  another  tool  for  evaluating  the  conformational 
change,” was monitored (Fig 5). Shimizu3’  previously showed 
that the addition of  ATP to bovine platelet myosin caused 
enhancement  of  the  intrinsic  tryptophane  fluorescence. 
Our results confirmed this finding, and further showed that 
the phosphorylation of myosin by MLC kinase, but not that 
by PKC, favors the transition from 10s  to 6s. 
The second  difference  is  that  PKC  phosphorylation, 
which itself had no effect on actin-activated Mg2+-ATPase 
activity of platelet myosin, inhibited the ATPase activity of 
platelet myosin prephosphorylated by  MLC kinase. It was 
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previously reported that  actin-activated  ATPase  activity 
of  smooth muscle HMM was inhibited by  PKC phosphory- 
lation.'0*'2  One  obvious concern  is  whether  or  not  this 
inhibition  is  related  to the inhibition  of  the 10s  to 6s 
conformational  change. KC1-dependence of  viscosity and 
MgZ'-ATPase activity were not influenced by PKC phospho- 
rylation, and additional change was not observed in myosin 
prephosphorylated  by  MLC  kinase  (Figs  4 and  5).  In 
addition,  analytical  ultracentrifugation  showed  that  the 
sedimentation coefficient at 0.2 mol/L KCI was almost the 
same for MLC kinase  phosphorylation  and MLC kinase 
plus PKC phosphorylation (Table 1).  These results were in 
contrast to those reported by Umekawa et  who showed 
that the PKC phosphorylation  of  smooth muscle myosin 
prephosphorylated by MLC kinase shifts the myosin confor- 
mation from 65 to lOS, by analytical ultracentrifugation and 
electron  microscopy.  In  contrast,  Ikebe  and  Reardon" 
reported recently that no change in the conformation  of 
bovine platelet myosin was observed after additional phos- 
phorylation  by  PKC to the MLC kinase  phosphorylated 
myosin, judging from the KC1-dependence of viscosity and 
ATPase  activity,  although  the  sedimentation  coefficient 
data were  not  shown. In  this  study, the Vmax of  actin- 
activated ATPase is markedly increased with prephosphory- 
lated myosin by MLC kinase. On the other hand, additional 
phosphorylation by  PKC increases the Ka without altering 
Vmax. These results together indicate that PKC phosphory- 
lation did not inhibit actin-activated M$'-ATPase  activity 
by inhibiting the conformational change of platelet myosin. 
One possible  explanation  for  the  inhibition  of  ATPase 
activity is that additional phosphorylation by PKC alters the 
affinity for actin, probably by  altering the subtle conforma- 
tion at the actin binding site on the myosin head. 
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